참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Trifluoroacetic acid | HCID 6422 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | 1,2-Diaminocyclohexane, cis- | HCID 342917 | — |
| 반응물 | 3-(1H-indazol-5-ylamino)-5-chloropyrazine-2-carboxamide | HCID 86685602 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | N-methyl-2-pyrrolidone | HCID 13387 | — |
| 생성물 | cis-3-(1H-indazol-5-ylamino)-5-(2-aminocyclohexylamino)pyrazine-2-carboxamide | HCID 86685601 | — |
반응 단계
To 3-(1H-indazol-5-ylamino)-5-chloropyrazine-2-carboxamide (˜100 mg) in ˜3 mL NMP was added 6 equivalents of DIEA and 20 equivalents of racemic cis-1,2-cyclohexanediamine. The mixture was heated at 150° C. in a sealed tube overnight. The reaction mixture was cooled, acidified with TFA, diluted with water and prepped via rpHPLC to give the title compound. MS found for C18H22N8O as (M+H)+367.2.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09359308B2 |
|---|
| 출처 데이터셋 | uspto-grants-2016_06 |
|---|
| ORD ID | ord-8f706c864dd44eba8f00c85172298f84 |
|---|
| 출처 메모 | uspto-grants-2016_06 |
|---|
